StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

TransMedics's revenue for the twelve months ending Jun 30, 2026 was $668.47M, up 25.8% year over year. For fiscal 2025 it was $605.49M, up 37.1% from the year before. The highest annual figure on record is $605.49M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$605.49M+37.1%
FY2024Dec 31, 2024$441.54M+82.7%
FY2023Dec 31, 2023$241.62M+158.5%
FY2022Dec 31, 2022$93.46M+208.8%
FY2021Dec 31, 2021$30.26M+18.0%
FY2020Dec 31, 2020$25.64M+8.6%
FY2019Dec 28, 2019$23.60M+81.3%
FY2018Dec 29, 2018$13.02M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$189.95M+20.7%
Q1 FY2026Mar 31, 2026$173.93M+21.2%
Q4 FY2025Dec 31, 2025$160.76M+32.2%
Q3 FY2025Sep 30, 2025$143.82M+32.2%
Q2 FY2025Jun 30, 2025$157.37M+37.7%
Q1 FY2025Mar 31, 2025$143.54M+48.2%
Q4 FY2024Dec 31, 2024$121.62M+49.8%
Q3 FY2024Sep 30, 2024$108.76M+63.7%
Q2 FY2024Jun 30, 2024$114.31M+117.9%
Q1 FY2024Mar 31, 2024$96.85M+133.1%
Q4 FY2023Dec 31, 2023$81.17M+158.7%
Q3 FY2023Sep 30, 2023$66.43M+158.7%
Q2 FY2023Jun 30, 2023$52.47M+155.7%
Q1 FY2023Mar 31, 2023$41.55M+161.7%
Q4 FY2022Dec 31, 2022$31.38M+224.5%
Q3 FY2022Sep 30, 2022$25.68M+378.3%
Q2 FY2022Jun 30, 2022$20.52M+151.1%
Q1 FY2022Mar 31, 2022$15.88M+125.2%
Q4 FY2021Dec 31, 2021$9.67M+26.8%
Q3 FY2021Sep 30, 2021$5.37M-24.3%
Q2 FY2021Jun 30, 2021$8.17M+141.0%
Q1 FY2021Mar 31, 2021$7.05M-6.3%
Q4 FY2020Dec 31, 2020$7.63M+25.9%
Q3 FY2020Sep 30, 2020$7.09M-1.6%
Q2 FY2020Jun 30, 2020$3.39M-40.2%
Q1 FY2020Mar 31, 2020$7.53M+61.0%
Q4 FY2019Dec 28, 2019$6.06M+70.9%
Q3 FY2019Sep 28, 2019$7.21M+78.4%
Q2 FY2019Jun 29, 2019$5.67M+94.4%
Q1 FY2019Mar 30, 2019$4.68M+85.6%
Q4 FY2018Dec 29, 2018$3.54M–
Q3 FY2018Sep 29, 2018$4.04M–
Q2 FY2018Jun 30, 2018$2.92M–
Q1 FY2018Mar 31, 2018$2.52M–

More TransMedics figures

See a number that looks wrong?